Call Anytime

+66 98-828-1773

At Dr. StemCellsThailand, we are dedicated to advancing the field of regenerative medicine through innovative cellular therapies and stem cell treatments. With over 20 years of experience, our expert team is committed to providing personalized care to patients from around the world, helping them achieve optimal health and vitality. We take pride in our ongoing research and development efforts, ensuring that our patients benefit from the latest advancements in stem cell technology. Our satisfied patients, who come from diverse backgrounds, testify to the transformative impact of our therapies on their lives, and we are here to support you on your journey to wellness.

Visiting Hours

Gallery Posts

Category: Pharmacology

Riluzole is a neuroprotective medication primarily used in the treatment of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects motor neurons in the brain and spinal cord. Approved by the FDA in 1995, it is the first drug shown to extend survival and time to tracheostomy in ALS patients.

Riluzole

Riluzole is a neuroprotective medication primarily used in the treatment of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects motor neurons in the brain and spinal cord. Approved by

Read More
Angiotensin II receptor blockers (ARBs) are a class of pharmaceuticals that selectively block the activation of angiotensin II type 1 receptors (AT1)[1]. These receptors mediate the effects of the renin-angiotensin system, which include arteriolar contraction and sodium retention[1]. By blocking AT1 receptors, ARBs lead to vasodilation, reduced vasopressin secretion, and decreased aldosterone production, ultimately lowering blood pressure[1]. ARBs are commonly known as angiotensin II receptor antagonists or AT~1~ receptor antagonists[1].

Angiotensin Receptor Blockers (ARBs)

Angiotensin II receptor blockers (ARBs) are a class of pharmaceuticals that selectively block the activation of angiotensin II type 1 receptors (AT1)[1]. These receptors mediate the effects of the renin-angiotensin system,

Read More